New brand also welcomes full-time CEO and expands product offerings

新品牌也欢迎全职首席执行官并扩展产品产品

NEW YORK, Oct. 1, 2023 /PRNewswire/ -- CIVCO Radiotherapy and Qfix announced today the launch of a new brand, CQ Medical. This brand reflects the company's vision and global leadership in high-quality, patient-centric radiotherapy solutions and more than 80 years of combined experience.

纽约，2023年10月1日/PRNewswire/-CIVCO Radiation和Qfix今天宣布推出新品牌CQ Medical。该品牌反映了公司在高质量，以患者为中心的放射治疗解决方案和80多年综合经验方面的愿景和全球领导力。

CQ Medical marks a pivotal transformation for CIVCO Radiotherapy and Qfix, who joined forces in October 2022. Under its new mantra, Care Smarter, CQ Medical will seek to expand on the company's history of innovative clinical solutions, unmatched product depth and breadth, and a passion for customer and patient care..

CQ Medical标志着CIVCO放射治疗和Qfix的关键转型，Qfix于2022年10月联席。根据其新的口号，Care Smarter，CQ Medical将寻求扩展公司创新临床解决方案的历史，无与伦比的产品深度和广度，以及对客户和患者护理的热情。。

The name CQ Medical is derived from the company's Care Quotient: IQ + EQ = CQ. It follows their philosophy of applying intelligence and empathy to everything they make and do.

CQ Medical的名称来源于公司的护理商：IQ+EQ=CQ。它遵循他们将智力和同理心应用于他们所做和做的一切的理念。

'Our new identity as CQ Medical embodies our commitment to driving innovation that improves cancer care and patient outcomes, as well as our deep engagement in the field with clinicians and technology partners,' said CQ Medical chief executive officer Mike Sutter. 'This will pave the way for us to emerge as a new global leader in innovative cancer therapy solutions.'.

CQ医疗首席执行官Mike Sutter说：“我们作为CQ Medical的新身份体现了我们致力于推动创新，改善癌症护理和患者预后，以及我们与临床医生和技术合作伙伴在该领域的深入参与。”这将为我们成为创新癌症治疗解决方案的新全球领导者铺平道路。

Leadership Announcement

领导公告

In addition to the brand launch, Mike Sutter has been named as the company's chief executive officer. After assuming the role in an interim capacity in April 2023, Mr. Sutter will lead the new CQ Medical as it continues to grow and improve patient care.

除了推出品牌外，Mike Sutter还被任命为该公司的首席执行官。在2023年4月担任临时职位后，Sutter先生将领导新的CQ医疗，因为它继续增长并改善患者护理。

'CQ Medical has a great culture and employees who are dedicated to continuously improving the radiotherapy experience both for patients and providers,' added Mr. Sutter. 'I look forward to continuing our mission to care smarter and keep the patient at the center of everything we do.'

Sutter先生补充说：“CQ Medical有着良好的文化和员工，致力于不断改善患者和提供者的放疗体验。”我期待继续我们的使命，更聪明地照顾患者，并将患者置于我们所做一切的中心。”

Mr. Sutter is also an Operating Partner at Blue Wolf Capital, a middle market private equity firm specializing in the healthcare and industrial sectors. He has nearly 40 years of experience working at all levels within industrial companies, serving in diverse markets with highly differentiated operating models.

Sutter先生还是Blue Wolf Capital的运营合作伙伴，Blue Wolf Capital是一家专门从事医疗保健和工业部门的中间市场私募股权公司。他在工业公司各级工作已有近40年的经验，在不同市场服务，具有高度差异化的运营模式。

His background includes a mix of general management, engineering, operations, supply chain, product management, financial oversight, and human capital development..

他的背景包括综合管理，工程，运营，供应链，产品管理，财务监督和人力资本开发。。

Nanovi A/S and Advaray Join CQ Medical

Nanovi A/S和Advaray加入CQ Medical

CQ Medical also announced it has acquired medical device companies Nanovi A/S and Advaray.

CQ Medical还宣布已收购医疗器械公司Nanovi A/S和Advaray。

Nanovi A/S is a Danish medical implant company specializing in precision marking for cancer therapy. Founded in 2013 as a spinout from the Technical University of Denmark, the firm brings pioneering technology that enables higher precision in radiation therapy and cancer surgery. Over its 10-year history, Nanovi has secured regulatory approval in both Europe and the U.S.

Nanovi A/S是一家丹麦医疗植入公司，专门从事癌症治疗的精确标记。该公司成立于2013年，是丹麦技术大学的一项杰出成果，开创性技术使放射治疗和癌症手术的精确度更高。Nanovi在其10年的历史中获得了欧洲和美国的监管部门批准。

while continuing to pursue its mission of better outcomes for cancer patients..

同时继续追求为癌症患者带来更好结果的使命。。

Based in Charlottesville, VA, Advaray is a medical device research and development company. It is developing a hydrogel-based device to improve methods of image-guided pelvic brachytherapy.

总部设在弗吉尼亚州夏洛茨维尔的Advaray是一家医疗器械研发公司。它正在开发一种基于水凝胶的装置，以改进图像引导骨盆近距离放射治疗的方法。

With these acquisitions, CQ Medical will add new solutions, most notably BioXmark (Nanovi) and BrachyGel (Advaray), to its already robust portfolio of product offerings.

通过这些收购，CQ Medical将为其已经强大的产品组合添加新的解决方案，最着名的是BioXmark（Nanovi）和BrachyGel（Advaray）。

About CQ Medical

关于CQ医疗

CQ Medical is a global leader in developing high-quality, innovative, patient-centric radiotherapy and cancer therapy solutions. With primary locations in Iowa and Pennsylvania and employees worldwide, the company has more than 80 years of combined experience bringing advanced hardware and consumables for patient immobilization and positioning, fiducial markers, couchtops, and patient care products to the market..

CQ Medical是开发高质量，创新，以患者为中心的放射治疗和癌症治疗解决方案的全球领导者。该公司在爱荷华州和宾夕法尼亚州拥有主要职位以及全球员工，拥有80多年的综合经验，为患者固定和定位，基准标记，Couchtop和患者护理产品带来先进的硬件和消耗品。。

For more information, visit cqmedical.com and find us on LinkedIn and Facebook.

欲了解更多信息，请访问cqmedical.com并在LinkedIn和Facebook上找到我们。

SOURCE CQ Medical

来源CQ医疗